Search results
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters· 5 days agoThe U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to ...
FTSE 100 Live 3 June: GSK shares tumble, Hollywood Bowl profits rise
Evening Standard via Yahoo Finance· 40 minutes agoGSK shares are today’s major focus after the drugs giant’s defence against Zantac claims suffered a...
SGLT2 Inhibitors Add to GLP-1s' Cardio, Kidney Benefits
Medscape· 3 hours agoThe largest analysis to date details added effects of SGLT2 inhibitors among those with type 2...
Journey to the center of the mirth
Politico· 4 days agoLet’s get into it. In today’s edition: → A military who’s who strutted around an airport-adjacent convention center. → First in Playbook: A pandemic vaccine contract inked with AstraZeneca ...
Cramer's Lighting Round: ‘You've got a winner' with Astra Zeneca
NBC Los Angeles· 3 days ago“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to...
AstraZeneca started at buy at Goldman, which rates GSK a neutral
Morningstar· 4 days agoGoldman Sachs started coverage of AstraZeneca at buy as it rated rival pharmaceutical company GSK a neutral. Analysts led by Rajan Sharma said AstraZeneca
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca
WROC Rochester· 5 days agoAs of the close of business on April...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 20 hours agoThe chemotherapy-antibody combinations, known as antibody drug conjugates, have been described as...
Cellectis Reports Financial Results for First Quarter 2024
Morningstar· 5 days ago• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca • Cash position of $143 million as of March 31, 20241; cash runway projection ...
Is Your Intellectual Property Safe With Indian CROs And CDMOs?
BioresearchOnline· 1 hour agoPlease note: This is not a legal document, although I have included input from attorneys based in...
